Drugs-Crime Nexus (Unit I)

In 1985 Paul Goldstein published a tripartite framework splitting drug-related violence into three mechanisms, arguing the well-known correlation between drug use and offending is not produced by one cause but by several distinct ones operating side by side. Criminologists routinely extend the framework beyond violence to drug-related property and market crime generally, because the same three logics apply there too.

The psychopharmacological pathway runs through the drug's direct effect on the user's brain and behaviour. The economic-compulsive pathway runs through the user's need for money once dependence has set in. The systemic pathway runs through the structure of the illegal market that supplies the drug, and would exist even if no user ever became intoxicated or stole anything.

Keeping the three apart matters for policy design. A response aimed at intoxicated violence does nothing to stop market turf wars, and a response aimed at market violence does nothing to reduce a bar fight, so treating drug crime as one undifferentiated category misallocates resources against at least two of the three problems it claims to solve.

The psychopharmacological pathway covers crime produced by a drug's direct chemical effect on cognition, mood or impulse control. Alcohol carries the strongest evidence here, well established in assault and domestic violence statistics, while opioids are sedating and typically reduce rather than raise the likelihood of violence while a person is intoxicated. This is why opioid-dependent offending clusters overwhelmingly in the economic-compulsive pathway instead.

The economic-compulsive pathway covers crime committed to raise money for a dependent habit, behind most shoplifting, burglary and theft documented among dependent users of expensive drugs such as heroin. Cohort studies find income-generating crime concentrated in periods of heaviest use and falling sharply once a user enters sustained treatment, which is the empirical basis for treatment-first sentencing alternatives such as drug courts.

The systemic pathway is the odd one out because it does not require anyone to be intoxicated or feeding a habit. It is violence generated by the structure of an illegal market itself: buyers and sellers of a prohibited good cannot use courts or contracts to settle disputes, so turf disputes, debt enforcement and robbery of dealers who cannot report the theft to police settle them instead.

Removing a dominant supplier can destabilise an existing equilibrium and trigger violent competition among remaining and new entrants, and closing one market tends to displace activity rather than eliminate it.

A harder problem sits underneath all three pathways: does drug use cause offending, does offending cause drug use, or does something upstream of both produce the correlation. Longitudinal cohort studies generally find minor delinquency typically precedes regular drug use rather than following it, while dependence then escalates further offending once it begins, mainly through the economic-compulsive pathway.

Shared upstream risk factors, such as family conflict, school failure and antisocial peers, predict both outcomes independently, so a study that ignores them risks attributing to the drug what is really a common cause.

Jurisdictions weight the three pathways differently in their statute books. The United Kingdom's Misuse of Drugs Act 1971 and India's Narcotic Drugs and Psychotropic Substances Act 1985, India's standalone drug statute, share an enforcement-led model built around supply and possession penalties; the 1985 Act was not affected by the 2023 replacement of the IPC, CrPC and Evidence Act with the BNS, BNSS and BSA.

The United States pioneered the drug court model, begun in Miami-Dade County in 1989, aimed squarely at the economic-compulsive pathway by diverting eligible defendants into supervised treatment. Evaluations generally find lower reoffending among graduates compared with conventionally prosecuted defendants.

Portugal's Law 30/2000, in force from 2001, removed criminal penalties for possession of small quantities of any drug for personal use, referring it instead to an administrative Commission for the Dissuasion of Drug Addiction, while leaving trafficking penalties unchanged. Enforcement targets supply, drug courts target the economic-compulsive pathway, and decriminalisation targets the harm of criminalising use itself, but none of the three alone touches the systemic pathway, which persists as long as any part of the trade stays illegal.